Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
NASDAQ:CGEN
Price:
1.88 USD
Market Closed
Updated:
Apr 19, 2024
Compugen Ltd
Operating Income
Last
Value
3-Years CAGR
5-Years CAGR
|
Compugen Ltd
Operating Income Peer Comparison
Comparables:
Q
QNRX
B
BOLT
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Compugen Ltd
NASDAQ:CGEN
|
Operating Income
$-13m
|
CAGR 3-Years
26%
|
CAGR 5-Years
11%
|
CAGR 10-Years
0%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Operating Income
$-9.4m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Operating Income
₪-10.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
9%
|
See Also
What is Compugen Ltd's Operating Income?
Operating Income
-13m
USD
-13m
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Operating Income amounts to -13m USD.
What is Compugen Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
0%
0%
Over the last year, the Operating Income growth was 63%. The average annual Operating Income growth rates for Compugen Ltd have been 26% over the past three years , 11% over the past five years .
You don't have any saved screeners yet
